Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Galkin Vladimir LUCY Innovative Eyewear Inc 13D/A 50.9% 2y
Versant Venture Capital VI, L.P. GLUE Monte Rosa Therapeutics, Inc. 13D/A 8.3% 2y
Saba Capital Management, L.P. VGM Invesco Trust for Investment Grade Municipals 13D/A 4.95% 2y
Sansone Advisors, LLC INFU InfuSystem Holdings, Inc 13D/A 6.8% 2y
Volition Capital Fund IV, L.P. GROV Grove Collaborative Holdings, Inc. 13D/A 27.2% 2y
Thomist Capital Management, LP BTU Peabody Energy Corp 13D/A 9.29% 2y
Nippon Shinyaku Co., Ltd. CAPR Capricor Therapeutics, Inc. 13G/A 18.9% 2y
HL Voting Trust HLI Houlihan Lokey, Inc. 13D/A 23.9% 2y
Klaus Umek CRTO Criteo S.A. 13D/A 3.77% 2y
PERCEPTIVE ADVISORS LLC VAPO Vapotherm, Inc. Common Stock 13D/A 100% 2y
Mason Ward PARA Parabolic Technologies, Inc. 13D/A 19.99% 2y
Liberty 77 Capital L.P. FLG Flagstar Bank, National Association 13D/A 18.1% 2y
KOONCE CALVIN SCOTT VSEC Vse Corp 13D/A 9.2% 2y
Ionic Ventures, LLC VVOS Vivos Therapeutics, Inc. 13G 8.7% 2y
Nantahala Capital Management, LLC CRMT Americas Carmart Inc 13D 6.7% 2y
MILLENNIUM MANAGEMENT LLC SILA Sila Realty Trust, Inc. 13G 1.7% 2y
Thomas A. Satterfield, Jr. INTT Intest Corp 13G 5.35% 2y
Zhang Minghui CHSN Chanson International Holding 13G 11.8% 2y
VEPF VIII SPV I, L.P. SMAR Smartsheet Inc. 13D 4.65% 2y
V Capital Consulting Limited YFOR YYForce Inc. 13G 5.29% 2y
Union Square Park Capital Management, LLC REED Reed's, Inc. 13D/A 14.8% 2y
TG Investment Ltd. CFOR CapForce Inc. 13G/A 7% 2y
Danone S.A. LWAY Lifeway Foods, Inc. 13D/A 23.4% 2y
Liberty Broadband Corporation CHTR Charter Communications, Inc. 13D/A 31.9% 2y
Riot Platforms, Inc. KEEL Keel Infrastructure Corp. 13D/A 19.9% 2y
MASAYA OTSUKA XPON Expion Energy, Inc. 13G 7.62% 2y
HORIZON KINETICS ASSET MANAGEMENT LLC LB LandBridge Corp 13D/A 29.5% 2y
Skorpios Trust STOK Stoke Therapeutics, Inc. 13D/A 16.9% 2y
Galkin Vladimir LUCY Innovative Eyewear Inc 13D/A 47.3% 2y
NOVO HOLDINGS A/S EWTX Edgewise Therapeutics, Inc. 13D/A 5.9% 2y
Silver Point Capital L.P. GPOR Gulfport Energy Corp 13D/A 30% 2y
8 Rivers Capital, LLC NPWR Net Power Inc. 13D/A 30.6% 2y
Saba Capital Management, L.P. ASA ASA Gold & Precious Metals Ltd 13D/A 16.87% 2y
MILLENNIUM MANAGEMENT LLC ADMA Adma Biologics, Inc. 13G 0.6% 2y
Michael Blitzer LUNR Intuitive Machines, Inc. 13D/A 4% 2y
Galkin Vladimir LUCY Innovative Eyewear Inc 13D/A 31.1% 2y
Yoshiyuki Aikawa SBC SBC Medical Group Holdings Inc 13D/A 92.3% 2y
Galkin Vladimir LUCY Innovative Eyewear Inc 13D/A 26.7% 2y
Norwest Venture Partners XVI, LP MBX MBX Biosciences, Inc. 13D 6.4% 2y
New Enterprise Associates 17, L.P. MBX MBX Biosciences, Inc. 13D 11.4% 2y
Longitude Capital Partners IV, LLC BCAX Bicara Therapeutics Inc. 13D 6% 2y
Galkin Vladimir LUCY Innovative Eyewear Inc 13D 21.1% 2y
James N. Topper MBX MBX Biosciences, Inc. 13D 18.8% 2y
ORBIMED ADVISORS LLC MBX MBX Biosciences, Inc. 13D 12% 2y
ENAVATE SCIENCES GP, LLC BCAX Bicara Therapeutics Inc. 13D 9% 2y
SR One Capital Management, LLC ZBIO Zenas BioPharma, Inc. 13D 12.3% 2y
Deep Track Capital, LP MBX MBX Biosciences, Inc. 13G 9.48% 2y
WHITEBOX ADVISORS LLC UP Wheels Up Experience Inc. 13G/A 6.2% 2y
Kore Advisors LP UP Wheels Up Experience Inc. 13G 3.7% 2y
Quanta Computer Inc. VUZI Vuzix Corp 13G 10.4% 2y